| |
| |
|
| Insider
Information: |
Mokari Atabak |
| Relationship: |
|
| City: |
Mountain View |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
91,323 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$452,149 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
91,323 |
|
|
| Total
Value |
$452,149 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Iridex Corp |
IRIX |
CFO and VP Corp Develo... |
2018-12-11 |
81,787 |
2016-07-27 |
0 |
Premium* |
|
|
Corcept Therapeutics Inc |
CORT |
|
2024-03-01 |
9,536 |
2022-09-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$13,329 |
D/D |
1,108 |
9,536 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2024-03-01 |
4 |
D |
$24.06 |
$12,439 |
D/D |
(517) |
8,428 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-12-01 |
4 |
A |
$0.00 |
$13,193 |
D/D |
1,016 |
8,945 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-09-01 |
4 |
A |
$0.00 |
$13,174 |
D/D |
796 |
8,204 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-06-01 |
4 |
A |
$0.00 |
$37,923 |
D/D |
3,302 |
7,408 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$25,024 |
D/D |
2,520 |
4,106 |
0 |
- |
|
| CORT |
Corcept Therapeutics Inc |
Chief Financial Officer |
• – – |
2022-09-01 |
4 |
A |
$0.00 |
$20,602 |
D/D |
1,586 |
1,586 |
0 |
- |
|
| IRIX |
Iridex Corp |
CFO and VP Corp Development |
• – – |
2018-12-11 |
4 |
D |
$4.10 |
$738 |
D/D |
(180) |
81,787 |
0 |
- |
|
| IRIX |
Iridex Corp |
CFO and VP Corp Development |
• – – |
2018-11-24 |
4 |
D |
$0.00 |
$0 |
D/D |
(5,833) |
81,967 |
0 |
- |
|
| IRIX |
Iridex Corp |
CFO and VP Corp Development |
• – – |
2018-07-28 |
4 |
A |
$0.00 |
$0 |
D/D |
16,800 |
87,800 |
0 |
- |
|
| IRIX |
Iridex Corp |
CFO and VP Corp Development |
• – – |
2017-07-24 |
4 |
A |
$9.54 |
$57,240 |
D/D |
6,000 |
71,000 |
0 |
- |
|
| IRIX |
Iridex Corp |
CFO and VP Corp Development |
• – – |
2016-07-27 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
65,000 |
0 |
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
